Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
2.845
+0.005 (0.18%)
Jun 4, 2026, 4:00 PM EDT - Market closed
Sensus Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 22.53 | 27.48 | 41.81 | 24.41 | 44.53 | 27.04 | |
Revenue Growth (YoY) | -42.94% | -34.27% | 71.30% | -45.20% | 64.68% | 182.36% |
Cost of Revenue | 14.03 | 15.62 | 17.38 | 10.35 | 14.9 | 10.05 |
Gross Profit | 8.5 | 11.87 | 24.43 | 14.06 | 29.63 | 16.99 |
Selling, General & Admin | 13.76 | 14.4 | 12.13 | 10.76 | 11.34 | 9.43 |
Research & Development | 6.76 | 7.78 | 4.22 | 3.68 | 3.46 | 3.44 |
Total Operating Expenses | 20.52 | 22.17 | 16.34 | 14.44 | 14.8 | 12.87 |
Operating Income | -12.02 | -10.31 | 8.09 | -0.38 | 14.83 | 4.12 |
Interest Income | 0.62 | 0.68 | 0.93 | 0.99 | 0.38 | 0 |
Interest Expense | - | - | - | - | - | -0 |
Other Non-Operating Income (Expense) | 0.78 | 0.68 | 0.93 | 1.08 | 25.94 | -0 |
Total Non-Operating Income (Expense) | 1.4 | 1.37 | 1.86 | 2.07 | 26.32 | -0 |
Pretax Income | -10.62 | -8.94 | 9.95 | 1.69 | 41.15 | 4.12 |
Provision for Income Taxes | -3.62 | -1.91 | 2.38 | 0.17 | 3.75 | - |
Net Income | -6.99 | -7.04 | 7.58 | 1.52 | 37.4 | 4.12 |
Net Income to Common | -6.99 | -7.04 | 7.58 | 1.52 | 37.4 | 4.12 |
Net Income Growth | - | - | 398.95% | -95.94% | 808.28% | - |
Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 16 | 16 |
Shares Outstanding (Diluted) | 16 | 16 | 16 | 16 | 17 | 17 |
Shares Change (YoY) | -0.05% | -0.20% | 0.57% | -2.12% | 0.70% | 0.42% |
EPS (Basic) | -0.47 | -0.47 | 0.41 | 0.03 | 1.47 | 0.25 |
EPS (Diluted) | -0.47 | -0.47 | 0.41 | 0.03 | 1.46 | 0.25 |
EPS Growth | - | - | 1266.67% | -97.95% | 484.00% | - |
Shares Outstanding | 16.46 | 16.46 | 16.5 | 16.37 | 16.39 | 16.62 |
Free Cash Flow | -0.74 | 0.33 | -1.11 | -2.37 | -1.57 | -0.41 |
Free Cash Flow Per Share | -0.05 | 0.02 | -0.07 | -0.15 | -0.09 | -0.03 |
Gross Margin | 37.74% | 43.18% | 58.44% | 57.61% | 66.53% | 62.82% |
Operating Margin | -53.34% | -37.50% | 19.35% | -1.57% | 33.30% | 15.24% |
Profit Margin | -31.04% | -25.60% | 18.13% | 6.22% | 83.99% | 15.23% |
FCF Margin | -3.28% | 1.21% | -2.65% | -9.73% | -3.53% | -1.53% |
EBITDA | -11.62 | -9.92 | 8.33 | -0.11 | 15.15 | 4.73 |
EBITDA Margin | -51.58% | -36.10% | 19.92% | -0.44% | 34.01% | 17.50% |
EBIT | -12.02 | -10.31 | 8.09 | -0.38 | 14.83 | 4.12 |
EBIT Margin | -53.34% | -37.50% | 19.35% | -1.57% | 33.30% | 15.24% |
Effective Tax Rate | 34.12% | 21.31% | 23.86% | 9.91% | 9.10% | 0.00% |